Read Simon

Insider CIK 1688199 · RARX Chief Scientific Officer · DNTH Director

Track record PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

Track record

See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.

Upgrade to Pro · $99/year Already Pro? Log in

Trades across companies

Ticker	Code	Trade	Filed	Shares	Price	Value	Owned after
DNTH Dianthus Therapeutics, Inc	M Exercise deriv	2026-08-19	2026-08-19	2,778	—	$0	19,445	SEC↗
DNTH Dianthus Therapeutics, Inc	S Sale	2026-08-19	2026-08-19	2,778	$117.55	$326.6K	0	SEC↗
DNTH Dianthus Therapeutics, Inc	M Exercise	2026-08-19	2026-08-19	2,778	$18.36	$51.0K	2,778	SEC↗
DNTH Dianthus Therapeutics, Inc	M Exercise deriv	2026-08-19	2026-08-19	2,778	—	$0	19,445	SEC↗
DNTH Dianthus Therapeutics, Inc	S Sale	2026-08-19	2026-08-19	2,778	$117.55	$326.6K	0	SEC↗
DNTH Dianthus Therapeutics, Inc	M Exercise	2026-08-19	2026-08-19	2,778	$18.36	$51.0K	2,778	SEC↗
DNTH Dianthus Therapeutics, Inc	M Exercise deriv	2026-08-10	2026-08-11	2,777	—	$0	22,223	SEC↗
DNTH Dianthus Therapeutics, Inc	S Sale	2026-08-10	2026-08-11	470	$111.05	$52.2K	397	SEC↗
DNTH Dianthus Therapeutics, Inc	S Sale	2026-08-10	2026-08-11	397	$111.77	$44.4K	0	SEC↗
DNTH Dianthus Therapeutics, Inc	S Sale	2026-08-10	2026-08-11	272	$109.96	$29.9K	867	SEC↗
DNTH Dianthus Therapeutics, Inc	S Sale	2026-08-10	2026-08-11	831	$108.95	$90.5K	1,139	SEC↗
DNTH Dianthus Therapeutics, Inc	S Sale	2026-08-10	2026-08-11	737	$108.17	$79.7K	1,970	SEC↗
DNTH Dianthus Therapeutics, Inc	S Sale	2026-08-10	2026-08-11	70	$107.11	$7.5K	2,707	SEC↗
DNTH Dianthus Therapeutics, Inc	M Exercise	2026-08-10	2026-08-11	2,777	$18.36	$51.0K	2,777	SEC↗
DNTH Dianthus Therapeutics, Inc	M Exercise deriv	2026-08-10	2026-08-11	2,777	—	$0	22,223	SEC↗
DNTH Dianthus Therapeutics, Inc	S Sale	2026-08-10	2026-08-11	397	$111.77	$44.4K	0	SEC↗
DNTH Dianthus Therapeutics, Inc	S Sale	2026-08-10	2026-08-11	470	$111.05	$52.2K	397	SEC↗
DNTH Dianthus Therapeutics, Inc	S Sale	2026-08-10	2026-08-11	272	$109.96	$29.9K	867	SEC↗
DNTH Dianthus Therapeutics, Inc	S Sale	2026-08-10	2026-08-11	831	$108.95	$90.5K	1,139	SEC↗
DNTH Dianthus Therapeutics, Inc	S Sale	2026-08-10	2026-08-11	737	$108.17	$79.7K	1,970	SEC↗
DNTH Dianthus Therapeutics, Inc	S Sale	2026-08-10	2026-08-11	70	$107.11	$7.5K	2,707	SEC↗
DNTH Dianthus Therapeutics, Inc	M Exercise	2026-08-10	2026-08-11	2,777	$18.36	$51.0K	2,777	SEC↗
DNTH Dianthus Therapeutics, Inc	A Award deriv	2026-05-21	2026-05-22	6,090	—	$0	6,090	SEC↗
DNTH Dianthus Therapeutics, Inc	A Award deriv	2025-05-22	2025-05-22	25,000	—	$0	25,000	SEC↗
RARX Ra Pharmaceuticals, Inc.	D To issuer deriv	2020-04-02	2020-04-03	107,000	—	$0	0	SEC↗
RARX Ra Pharmaceuticals, Inc.	D To issuer deriv	2020-04-02	2020-04-03	9,166	—	$0	0	SEC↗
RARX Ra Pharmaceuticals, Inc.	D To issuer deriv	2020-04-02	2020-04-03	55,000	—	$0	0	SEC↗
RARX Ra Pharmaceuticals, Inc.	D To issuer deriv	2020-04-02	2020-04-03	46,434	—	$0	0	SEC↗
RARX Ra Pharmaceuticals, Inc.	D To issuer deriv	2020-04-02	2020-04-03	26,422	—	$0	0	SEC↗
RARX Ra Pharmaceuticals, Inc.	D To issuer deriv	2020-04-02	2020-04-03	25,000	—	$0	0	SEC↗
RARX Ra Pharmaceuticals, Inc.	D To issuer deriv	2020-04-02	2020-04-03	67,500	—	$0	0	SEC↗
RARX Ra Pharmaceuticals, Inc.	D To issuer	2020-04-02	2020-04-03	12,595	$48.00	$604.6K	0	SEC↗
RARX Ra Pharmaceuticals, Inc.	M Exercise deriv	2019-12-17	2019-12-18	10,000	—	$0	46,142	SEC↗
RARX Ra Pharmaceuticals, Inc.	S Sale	2019-12-17	2019-12-18	10,000	$47.08	$470.8K	6,234	SEC↗
RARX Ra Pharmaceuticals, Inc.	M Exercise	2019-12-17	2019-12-18	10,000	$2.87	$28.7K	16,234	SEC↗
RARX Ra Pharmaceuticals, Inc.	M Exercise deriv	2019-11-14	2019-11-18	10,000	—	$0	56,142	SEC↗
RARX Ra Pharmaceuticals, Inc.	S Sale	2019-11-14	2019-11-18	10,000	$46.68	$466.8K	6,234	SEC↗
RARX Ra Pharmaceuticals, Inc.	M Exercise	2019-11-14	2019-11-18	10,000	$2.87	$28.7K	16,234	SEC↗
RARX Ra Pharmaceuticals, Inc.	M Exercise deriv	2019-10-16	2019-10-17	10,000	—	$0	66,142	SEC↗
RARX Ra Pharmaceuticals, Inc.	M Exercise	2019-10-16	2019-10-17	10,000	$2.87	$28.7K	16,234	SEC↗
RARX Ra Pharmaceuticals, Inc.	S Sale	2019-10-16	2019-10-17	10,000	$46.87	$468.7K	6,234	SEC↗
RARX Ra Pharmaceuticals, Inc.	M Exercise deriv	2019-09-12	2019-09-16	10,000	—	$0	76,142	SEC↗
RARX Ra Pharmaceuticals, Inc.	M Exercise	2019-09-12	2019-09-16	10,000	$2.87	$28.7K	16,234	SEC↗
RARX Ra Pharmaceuticals, Inc.	S Sale	2019-09-12	2019-09-16	10,000	$25.41	$254.1K	6,234	SEC↗
RARX Ra Pharmaceuticals, Inc.	M Exercise deriv	2019-08-23	2019-08-27	10,000	—	$0	86,142	SEC↗
RARX Ra Pharmaceuticals, Inc.	M Exercise	2019-08-23	2019-08-27	10,000	$2.87	$28.7K	16,234	SEC↗
RARX Ra Pharmaceuticals, Inc.	S Sale	2019-08-23	2019-08-27	10,000	$27.77	$277.7K	6,234	SEC↗
RARX Ra Pharmaceuticals, Inc.	M Exercise deriv	2019-07-17	2019-07-18	10,000	—	$0	96,142	SEC↗
RARX Ra Pharmaceuticals, Inc.	M Exercise	2019-07-17	2019-07-18	10,000	$2.87	$28.7K	16,234	SEC↗
RARX Ra Pharmaceuticals, Inc.	S Sale	2019-07-17	2019-07-18	10,000	$32.95	$329.5K	6,234	SEC↗
RARX Ra Pharmaceuticals, Inc.	M Exercise deriv	2019-06-18	2019-06-19	10,000	—	$0	106,142	SEC↗
RARX Ra Pharmaceuticals, Inc.	M Exercise	2019-06-18	2019-06-19	10,000	$2.87	$28.7K	16,234	SEC↗
RARX Ra Pharmaceuticals, Inc.	S Sale	2019-06-18	2019-06-19	414	$23.09	$9.6K	6,234	SEC↗
RARX Ra Pharmaceuticals, Inc.	S Sale	2019-06-18	2019-06-19	9,586	$22.21	$212.9K	6,648	SEC↗
RARX Ra Pharmaceuticals, Inc.	M Exercise deriv	2019-02-01	2019-02-05	9,167	—	$0	18,333	SEC↗
RARX Ra Pharmaceuticals, Inc.	A Award deriv	2019-02-01	2019-02-05	107,000	—	$0	107,000	SEC↗
RARX Ra Pharmaceuticals, Inc.	F Tax w/h	2019-02-01	2019-02-05	2,933	$21.00	$61.6K	6,234	SEC↗
RARX Ra Pharmaceuticals, Inc.	M Exercise	2019-02-01	2019-02-05	9,167	—	$0	9,167	SEC↗
RARX Ra Pharmaceuticals, Inc.	A Award deriv	2018-02-01	2018-02-05	27,500	—	$0	27,500	SEC↗
RARX Ra Pharmaceuticals, Inc.	A Award deriv	2018-02-01	2018-02-05	55,000	—	$0	55,000	SEC↗
RARX Ra Pharmaceuticals, Inc.	A Award deriv	2017-02-01	2017-02-03	67,500	—	$0	67,500	SEC↗